Prophylactic Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest
NCT02899507 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2016-09-14
Summary
The purpose of this study is to determine whether there is potential benefits of prophylactic antibiotic treatment in comatose survivors of out-of-hospital cardiac arrest (OHCA) treated in intensive care unit with therapeutic hypothermia.
Conditions
- Out-of-hospital Cardiac Arrest
Interventions
- DRUG
-
Amoxicillin-Clavulanic acid
Patients without evidence of tracheobronchial aspiration were randomized to immediate prophylactic Amoxicillin-Clavulanic acid 1,2 gr/8h
Sponsors & Collaborators
-
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Marko Noč, MD, PhD · University Medical Centre Ljubljana
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2015-03-31
- Completion
- 2015-04-30
Countries
- Slovenia
Study Locations
More Related Trials
-
Procalcitonin to Guide Antibiotic Stop in Neurocritical Care Patients.
NCT03683693 ·Status: UNKNOWN ·Phase: NA
-
Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors
NCT03628300 ·Status: COMPLETED
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock
NCT05027529 ·Status: COMPLETED ·Phase: NA
-
Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in Sepsis.
NCT03422159 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department
NCT02365272 ·Status: COMPLETED ·Phase: PHASE4
-
Acetyl-L-Carnitine in the Treatment of Septic Shock
NCT00592488 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
NCT00279214 ·Status: COMPLETED ·Phase: PHASE4
-
Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients
NCT02294695 ·Status: COMPLETED
-
Short-course Antimicrobial Therapy in Sepsis
NCT02899143 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficiency of Combined Extracorporeal Blood Purification in Neurosurgical ICU. Prospective RCT
NCT04152174 ·Status: UNKNOWN ·Phase: NA
-
Resuscitation Strategies in Septic Shock
NCT02150512 ·Status: UNKNOWN ·Phase: NA
-
Vitamin C, Thiamine, Cyanocobalamine, Pyridoxine and Hydrocortisone in Sepsis
NCT04197115 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis
NCT04773717 ·Status: COMPLETED ·Phase: NA
-
Propafenone Versus Amiodarone in Septic Shock
NCT03029169 ·Status: COMPLETED ·Phase: PHASE4
-
Improvement of Cerebrovascular Autoregulation in Patients With Septic Shock Due to Cytokine Elimination
NCT04259567 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock
NCT04111822 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
Severe Septic Shock Complications
NCT03716895 ·Status: UNKNOWN
-
The Effect of Remote Ischemic Conditioning on the Microcirculation in Sepsis
NCT04644926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mortality Due to Septic Shock Associated With Thrombocytopenia
NCT03617965 ·Status: UNKNOWN
-
Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.
NCT01411670 ·Status: COMPLETED ·Phase: PHASE2
-
Imipenem/Cilastatin/Relebactam PK in ECMO
NCT04493151 ·Status: COMPLETED ·Phase: PHASE1
-
Shock and Acute Conditions OutcOmes Platform
NCT06376318 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Ketanserin on the Microcirculation in Sepsis
NCT01329887 ·Status: COMPLETED ·Phase: PHASE3